Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 17496059)

Published in Am J Physiol Lung Cell Mol Physiol on May 11, 2007

Authors

Shilpa Vyas-Read1, Philip W Shaul, Ivan S Yuhanna, Brigham C Willis

Author Affiliations

1: Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9063, USA.

Articles citing this

Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med (2009) 1.61

Melatonin inhibits endoplasmic reticulum stress and epithelial-mesenchymal transition during bleomycin-induced pulmonary fibrosis in mice. PLoS One (2014) 1.43

Inflammatory levels of nitric oxide inhibit airway epithelial cell migration by inhibition of the kinase ERK1/2 and activation of hypoxia-inducible factor-1 alpha. J Biol Chem (2008) 1.08

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. Mol Biol Cell (2009) 1.02

Harvesting, identification and barrier function of human lung microvascular endothelial cells. Vascul Pharmacol (2010) 1.01

Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide (2011) 0.99

Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol (2010) 0.92

Innovative approaches to the therapy of fibrosis. Curr Opin Rheumatol (2009) 0.88

Hepatocyte growth factor in lung repair and pulmonary fibrosis. Acta Pharmacol Sin (2010) 0.87

A breath of fresh air on the mesenchyme: impact of impaired mesenchymal development on the pathogenesis of bronchopulmonary dysplasia. Front Med (Lausanne) (2015) 0.85

Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition. Am J Physiol Lung Cell Mol Physiol (2013) 0.83

Replicative aging induces endothelial to mesenchymal transition in human aortic endothelial cells: potential role of inflammation. J Vasc Res (2011) 0.83

Bronchopulmonary dysplasia early changes leading to long-term consequences. Front Med (Lausanne) (2015) 0.82

Early injury of the neonatal lung contributes to premature lung aging: a hypothesis. Mol Cell Pediatr (2016) 0.82

Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice. Respir Res (2014) 0.81

Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. Pulm Med (2011) 0.80

Effect of nitric oxide deficiency on the pulmonary PTHrP system. J Cell Mol Med (2016) 0.77

Prolonged nitric oxide exposure enhances anoikis resistance and migration through epithelial-mesenchymal transition and caveolin-1 upregulation. Biomed Res Int (2014) 0.75

Mesenchymal stem cells in combination with erythropoietin repair hyperoxia-induced alveoli dysplasia injury in neonatal mice via inhibition of TGF-β1 signaling. Oncotarget (2016) 0.75

Plasma Vascular Endothelial Growth Factor Concentration and Alveolar Nitric Oxide as Potential Predictors of Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis. J Clin Med (2016) 0.75

Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs. Am J Transl Res (2010) 0.75

Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Inhaled Nitric Oxide. PLoS One (2017) 0.75

Articles by these authors

HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med (2014) 8.61

Endothelial and antithrombotic actions of HDL. Circ Res (2006) 2.68

Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1. Am J Respir Cell Mol Biol (2007) 2.50

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science (2002) 2.45

27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med (2007) 2.18

FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res (2005) 1.97

Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev (2002) 1.97

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem (2003) 1.92

Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest (2010) 1.90

C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res (2007) 1.82

High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res (2005) 1.77

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J Clin Invest (2010) 1.77

27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol (2007) 1.75

Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res (2002) 1.74

ERbeta has nongenomic action in caveolae. Mol Endocrinol (2002) 1.73

Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest (2005) 1.62

Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase. Circ Res (2003) 1.58

Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol (2004) 1.56

27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep (2013) 1.39

Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α . Mol Endocrinol (2007) 1.33

Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. Am J Respir Cell Mol Biol (2010) 1.32

The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res (2008) 1.25

Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci U S A (2013) 1.21

Signaling by the high-affinity HDL receptor scavenger receptor B type I. Arterioscler Thromb Vasc Biol (2010) 1.21

Novel biological functions of high-density lipoprotein cholesterol. Circ Res (2012) 1.19

C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation (2007) 1.19

Effect of ductus ligation on cardiopulmonary function in premature baboons. Am J Respir Crit Care Med (2005) 1.15

Non-nuclear estrogen receptor signaling in the endothelium. J Biol Chem (2011) 1.13

Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ Res (2012) 1.13

Effects of transdifferentiation and EGF on claudin isoform expression in alveolar epithelial cells. J Appl Physiol (1985) (2004) 1.11

Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol (2003) 1.08

Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. Am J Physiol Cell Physiol (2011) 1.07

Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERalpha domains with known nuclear functions. Mol Endocrinol (2004) 1.04

HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action. Trends Cardiovasc Med (2003) 1.02

Functions of scavenger receptor class B, type I in atherosclerosis. Curr Opin Lipidol (2012) 1.02

Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit. Cardiol Young (2009) 1.02

Caveolin-1 is not required for murine intestinal cholesterol transport. J Biol Chem (2005) 0.99

Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc Res (2006) 0.98

Regulation of signal transduction by HDL. J Lipid Res (2013) 0.97

Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair. Trends Cardiovasc Med (2007) 0.96

Inhaled nitric oxide: effects on cerebral growth and injury in a baboon model of premature delivery. Pediatr Res (2007) 0.96

C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes (2012) 0.96

Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae. Steroids (2002) 0.95

Postnatal estradiol up-regulates lung nitric oxide synthases and improves lung function in bronchopulmonary dysplasia. Am J Respir Crit Care Med (2009) 0.94

27-Hydroxycholesterol: the first identified endogenous SERM. Trends Endocrinol Metab (2011) 0.94

Molecular basis of estrogen-induced cyclooxygenase type 1 upregulation in endothelial cells. Circ Res (2005) 0.93

C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1. Circ Res (2009) 0.93

Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass. Mol Endocrinol (2013) 0.93

Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res (2005) 0.93

Regulation of eNOS in caveolae. Adv Exp Med Biol (2012) 0.92

Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J (2007) 0.91

Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function. Circ Res (2011) 0.90

PON-dering differences in HDL function in coronary artery disease. J Clin Invest (2011) 0.90

Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons. Pediatr Res (2011) 0.89

Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease. Am J Respir Cell Mol Biol (2005) 0.88

Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir Cell Mol Biol (2002) 0.85

G-CSF exerts dual effects on endothelial cells--opposing actions of direct eNOS induction versus indirect CRP elevation. J Mol Cell Cardiol (2008) 0.84

Estimation of paracellular conductance of primary rat alveolar epithelial cell monolayers. J Appl Physiol (1985) (2004) 0.84

Hypoxia-induced left ventricular dysfunction in myoglobin-deficient mice. Am J Physiol Heart Circ Physiol (2003) 0.83

Point mutations in the ERα Gαi binding domain segregate nonnuclear from nuclear receptor function. Mol Endocrinol (2012) 0.82

LXRβ/estrogen receptor-α signaling in lipid rafts preserves endothelial integrity. J Clin Invest (2013) 0.81

New Insights into the Molecular Basis of the Antiphospholipid Syndrome. Drug Discov Today Dis Mech (2011) 0.81

Epithelial-mesenchymal transition: potential role in obliterative bronchiolitis? Thorax (2009) 0.79

Inhaled nitric oxide and bronchopulmonary dysplasia. Pediatrics (2011) 0.78

Conventional estrogen receptors are found in the plasma membrane of vaginal epithelial cells of the rat. Steroids (2002) 0.77

Meconium increases type 1 angiotensin II receptor expression and alveolar cell death. Pediatr Res (2008) 0.77

The effects of postnatal estrogen therapy on brain development in preterm baboons. Am J Obstet Gynecol (2010) 0.76

Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs. Am J Transl Res (2010) 0.75

HDL cholesterol efflux capacity and cardiovascular events. N Engl J Med (2015) 0.75

Immunosuppression-induced bronchial epithelial-mesenchymal transition: a potential contributor to obliterative bronchiolitis. J Thorac Cardiovasc Surg (2010) 0.75